ArticleFrontiers in immunology2022

Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect.

Xiaying Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.